Environment. Pharmaceutical industries studying to treat covid-19? Basically, all those that may have a potential therapeutic application. Today, logically, a large part of the efforts of the pharmaceutical industry are directed at curbing the terrible consequences of the covid-19 pandemic that currently exists. For this reason, the role of msls becomes crucial in the fight against this disease: from their position as scientific advisers and experts in the different drugs, it is their duty to contribute ideas that give rise to new lines of research that can result in solutions to the global health problem posed by covid-19. Experts in each scientific area of all pharmaceutical industries have
devoted great efforts to carrying out an exhaustive search within the current pharmacological arsenal, with the aim of linking the therapeutic characteristics of existing drugs with an improvement in the evolution of the disease caused by coronavirus. Some of the e commerce photo editing service drugs that have made the most noise in the media due to the promising studies that have been published on them to date are: remdesivir, acyclovir, hydroxychloroquine... And dexamethasone, which we will delve deeper into in this article. Dexamethasone is a corticosteroid , used in numerous conditions, from cerebral edema to asthma attacks, due to its anti- inflammatory and immunosuppressive properties .
It is important to point out two aspects about treatment with dexamethasone in covid-19: its use is only recommended in seriously ill patients who require oxygen therapy. Explained in broad strokes, dexamethasone does not contribute anything to our body in terms of fighting the virus, but rather improves the respiratory response , contributing to the effectiveness of oxygen therapy. This, according to the recovery study(randomized